药剂师主导的数字干预对喘结果的影响:系统性审查
Michaela Bell1, Brianne Burns1, Amber King1
1Jefferson College of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Philadelphia, PA, 19107.
Journal of the American Pharmacists Association : JAPhA
|February 22, 2026
概括
药剂师主导的数字工具在改善药物坚持和喘控制方面表现有前途. 需要对患者满意度,成本和药剂师对综合性喘管理的观点进行进一步的研究.
科学领域:
- 药房实践 在药房实践中
- 数字健康数字健康
- 喘管理 喘管理
背景情况:
- 有效的喘管理对于预防恶化,加强控制和降低医疗保健成本至关重要.
- 药剂师主导的数字工具使药剂师能够在整个疾病过程中提供更好的患者支持.
研究的目的:
- 评估药剂师主导的数字干预对药物坚持和喘控制的影响.
- 评估患者的满意度,药剂师的看法,以及在喘管理中使用的行为改变技术 (BCT).
主要方法:
- 2024年9月,在PubMed,PsycINFO和CINAHL进行了系统的文献搜索,并补充了灰色文献搜索.
- 搜索包括与喘,药房实践和数字健康相关的术语,并于2025年9月重复搜索.
- 包括9项研究,使用各种数字工具,如远程医疗,教育视频,自我管理应用程序和数据挖掘软件.
主要成果:
- 五项研究中有四项报告了对药物坚持的积极影响,八项研究中有七项报告了对喘控制的积极影响.
- 八种行为改变技术 (BCT) 用于提高坚持和吸入器技术.
- 在两项研究中,患者满意度是积极的,一项研究表明节省了成本;药剂师的看法没有被评估.
结论:
- 药剂师主导的数字干预显示出改善药物服药和控制喘的巨大潜力.
- 虽然BCT被广泛应用,但其多样性是有限的,并且存在关于患者满意度,经济结果和药剂师观点的研究差距.
更多相关视频
相关概念视频
01:23Inhaled Medications
889
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
889
01:30Asthma-IV: Nursing Management
3.9K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.9K
01:30Asthma-IV: Diagnostic and Management
3.2K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.0K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.0K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.3K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.3K
01:26COPD: Management Using Bronchodilators and Corticosteroids
907
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
907